YTHDC2 and neoplasm: The expression levels of ALKBH5, FTO, KIAA1429, METTL3, RBM15, WTAP, and YTHDC2 were significantly higher in tumor tissues, while expression levels of FMR1, HNRNPA2B1, LRPPRC, METTL14, RBM15B, YTHDF2, YTHDF3 and ZC3H13 were significantly decreased in tumor tissues.